Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

ORIC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.34%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $618,788.40

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

^$8.07

▲ +0.4 (5.22%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

4 simple steps to protect your privacy and money before it’s too late.

ORIC Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/6/2024	Jacob Chacko	CEO	Sell	13,958	$12.12	$169,170.96	794,586
12/15/2023	Jacob Chacko	CEO	Sell	14,539	$8.58	$124,744.62	808,544
12/15/2023	Pratik S Multani	Insider	Sell	5,282	$8.59	$45,372.38	23,809
7/10/2023	Jacob Chacko	CEO	Sell	10,508	$8.01	$84,169.08	785,808
7/5/2023	Jacob Chacko	CEO	Sell	4,336	$8.01	$34,731.36	796,316
6/26/2023	Jacob Chacko	CEO	Sell	20,000	$8.03	$160,600.00	800,652
12/15/2022	Jacob Chacko	CEO	Sell	5,764	$3.25	$18,733.00	817,025
12/15/2022	Pratik S Multani	Insider	Sell	2,089	$3.25	$6,789.25	7,423
5/13/2022	Jacob Chacko	CEO	Buy	76,072	$2.82	$214,523.04	802,652
5/11/2022	Jacob Chacko	CEO	Buy	304,574	$2.90	$883,264.60	657,226
3/31/2022	Dominic Piscitelli	CFO	Buy	60,000	$5.36	$321,600.00
3/25/2022	Jacob Chacko	CEO	Buy	50,000	$4.54	$227,000.00
3/23/2022	Jacob Chacko	CEO	Buy	257,127	$4.98	$1,280,492.46
9/15/2021	Jacob Chacko	CEO	Sell	3,736	$25.06	$93,624.16	6,388
9/14/2021	Richard A. Heyman	Director	Sell	706	$25.05	$17,685.30	12,500
9/13/2021	Jacob Chacko	CEO	Sell	2,801	$25.02	$70,081.02	6,388
9/10/2021	Jacob Chacko	CEO	Sell	2,942	$25.08	$73,785.36
9/7/2021	Jacob Chacko	CEO	Sell	5,981	$25.11	$150,182.91	16,751
9/7/2021	Richard A Heyman	Director	Sell	1,086	$25.11	$27,269.46	12,500
5/24/2021	Jacob Chacko	CEO	Sell	12	$25.00	$300.00	27,934
5/24/2021	Richard A Heyman	Director	Sell	100	$25.00	$2,500.00	12,500
5/20/2021	Jacob Chacko	CEO	Sell	2,468	$25.07	$61,872.76	27,934
5/20/2021	Richard A Heyman	Director	Sell	700	$25.08	$17,556.00	12,500
5/17/2021	Richard A Heyman	Director	Sell	498	$25.07	$12,484.86	12,500
5/13/2021	Jacob Chacko	CEO	Sell	730	$25.04	$18,279.20	59,310
5/13/2021	Richard H. Scheller	Director	Sell	100	$25.00	$2,500.00	49,200
5/11/2021	Jacob Chacko	CEO	Sell	1,090	$25.22	$27,489.80	59,310
5/11/2021	Richard A Heyman	Director	Sell	100	$25.11	$2,511.00	49,200
4/30/2021	Jacob Chacko	CEO	Sell	1,300	$25.14	$32,682.00	61,000
4/30/2021	Richard A Heyman	Director	Sell	100	$25.26	$2,526.00	12,500
4/28/2021	Jacob Chacko	CEO	Sell	700	$25.06	$17,542.00	61,000
4/28/2021	Richard A Heyman	Director	Sell	100	$25.08	$2,508.00	12,500

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

95.05% of ORIC Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/13/2024	Tower Research Capital LLC TRC	9,255	$85K	0.0%	+19.6%	0.014%
2/7/2024	Monaco Asset Management SAM	280,000	$2.58M	0.8%	-27.2%	0.416%
2/7/2024	Vivo Capital LLC	849,681	$7.82M	0.6%	+9.2%	1.261%
2/6/2024	AJOVista LLC	4,357	$40K	0.1%	N/A	0.006%
2/6/2024	M&T Bank Corp	83,926	$0.77M	0.0%	+18.3%	0.125%
2/5/2024	Victory Capital Management Inc.	126,030	$1.16M	0.0%	+0.9%	0.187%
2/1/2024	New York State Common Retirement Fund	9,570	$88K	0.0%	-39.0%	0.014%
1/30/2024	Strs Ohio	7,900	$72K	0.0%	N/A	0.014%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	22,043	$0.20M	0.0%	+6.6%	0.040%
1/24/2024	China Universal Asset Management Co. Ltd.	6,305	$58K	0.0%	N/A	0.012%
12/1/2023	Euclidean Capital LLC	989,410	$5.99M	1.3%	+32.4%	1.814%
11/15/2023	Alkeon Capital Management LLC	3,479,289	$21.05M	0.0%	+16.8%	6.378%
11/14/2023	Sherbrooke Park Advisers LLC	11,911	$72K	0.0%	N/A	0.022%
11/13/2023	Algert Global LLC	13,430	$81K	0.0%	N/A	0.025%
11/13/2023	Acadian Asset Management LLC	22,691	$0.14M	0.0%	-86.7%	0.042%
11/13/2023	Silverarc Capital Management LLC	1,123,345	$6.80M	2.1%	-22.6%	2.059%
11/13/2023	FMR LLC	3,132,194	$18.95M	0.0%	-16.1%	5.742%
11/8/2023	Vivo Capital LLC	777,944	$4.71M	0.6%	N/A	1.427%
11/7/2023	Monaco Asset Management SAM	384,793	$2.33M	0.7%	+1.7%	0.706%
11/7/2023	Jump Financial LLC	32,149	$0.20M	0.0%	+104.8%	0.059%
11/6/2023	Victory Capital Management Inc.	124,850	$0.76M	0.0%	-8.9%	0.229%
9/21/2023	Barclays PLC	7,772	$61K	0.0%	N/A	0.014%
8/15/2023	Silverarc Capital Management LLC	1,450,822	$11.26M	3.5%	+1.0%	2.661%
8/15/2023	Suvretta Capital Management LLC	492,924	$3.83M	0.2%	-74.1%	0.904%
8/15/2023	Boxer Capital LLC	1,732,571	$13.45M	0.6%	+64.4%	3.177%
8/14/2023	ArrowMark Colorado Holdings LLC	1,417,873	$11M	0.1%	+454.4%	3.144%
8/14/2023	Prosight Management LP	2,761,468	$21.43M	6.6%	+78.7%	5.064%
8/11/2023	VR Adviser LLC	2,142,856	$16.63M	2.7%	N/A	4.752%
8/11/2023	Pale Fire Capital SE	33,055	$0.26M	0.0%	N/A	0.073%
8/8/2023	Monaco Asset Management SAM	378,222	$2.94M	0.8%	-31.5%	0.839%
8/7/2023	Acadian Asset Management LLC	170,488	$1.32M	0.0%	+30.5%	0.378%
8/4/2023	American International Group Inc.	18,787	$0.15M	0.0%	N/A	0.042%
7/27/2023	Victory Capital Management Inc.	137,030	$1.06M	0.0%	-13.5%	0.304%
7/27/2023	Virtu Financial LLC	11,831	$92K	0.0%	-39.7%	0.026%
7/10/2023	SG Americas Securities LLC	23,150	$0.18M	0.0%	N/A	0.051%
5/15/2023	Atom Investors LP	65,779	$0.38M	0.2%	-46.9%	0.146%
5/12/2023	Prosight Management LP	1,545,000	$8.81M	4.2%	+30.9%	3.426%
5/11/2023	Acadian Asset Management LLC	130,655	$0.74M	0.0%	+2.2%	0.290%
5/3/2023	Jump Financial LLC	24,349	$0.14M	0.0%	N/A	0.054%
5/2/2023	Victory Capital Management Inc.	158,430	$0.90M	0.0%	N/A	0.351%
5/1/2023	Virtu Financial LLC	19,624	$0.11M	0.0%	N/A	0.044%
2/15/2023	Alkeon Capital Management LLC	2,399,252	$14.13M	0.1%	+13.9%	6.062%
2/15/2023	Atom Investors LP	123,821	$0.73M	0.4%	-5.1%	0.313%
2/14/2023	683 Capital Management LLC	33,800	$0.20M	0.0%	N/A	0.085%
2/13/2023	GSA Capital Partners LLP	238,359	$1.40M	0.2%	+5.7%	0.602%
2/13/2023	Cornercap Investment Counsel Inc.	46,485	$0.27M	0.0%	-32.7%	0.117%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	41,635	$0.25M	0.0%	-18.1%	0.105%
2/1/2023	Bank of Montreal Can	107,688	$0.64M	0.0%	N/A	0.272%
1/31/2023	Monaco Asset Management SAM	557,430	$3.28M	0.9%	+63.4%	1.408%
11/15/2022	Prosight Management LP	936,334	$3M	1.6%	N/A	2.366%
11/14/2022	Point72 Asset Management L.P.	10,000	$32K	0.0%	N/A	0.025%
11/14/2022	Ergoteles LLC	83,835	$0.27M	0.0%	-45.2%	0.212%
11/14/2022	UBS Oconnor LLC	343,002	$1.10M	0.0%	-5.0%	0.867%
11/14/2022	Hsbc Holdings PLC	60,000	$0.19M	0.0%	+71.4%	0.152%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	50,809	$0.16M	0.0%	+141.2%	0.128%
11/8/2022	Atom Investors LP	130,541	$0.42M	0.1%	+65.8%	0.330%
10/31/2022	Monaco Asset Management SAM	341,182	$1.09M	0.4%	-6.5%	0.862%
10/28/2022	Silverarc Capital Management LLC	1,208,992	$3.87M	1.3%	+11.7%	3.055%
10/18/2022	Bailard Inc.	38,505	$0.12M	0.0%	N/A	0.097%
8/16/2022	DAFNA Capital Management LLC	415,926	$1.86M	0.5%	N/A	1.051%
8/15/2022	Laurion Capital Management LP	11,940	$53K	0.0%	N/A	0.030%
8/11/2022	Beacon Pointe Advisors LLC	10,040	$44K	0.0%	N/A	0.025%
8/8/2022	Y Intercept Hong Kong Ltd	10,828	$49K	0.0%	N/A	0.027%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	21,063	$94K	0.0%	N/A	0.053%
8/1/2022	Monaco Asset Management SAM	364,741	$1.63M	0.7%	N/A	0.924%
7/25/2022	Allspring Global Investments Holdings LLC	65,716	$0.29M	0.0%	-93.3%	0.166%
7/25/2022	Silverarc Capital Management LLC	1,082,304	$4.85M	1.5%	N/A	2.742%
5/20/2022	International Biotechnology Trust PLC	176,217	$0.91M	0.2%	+15.2%	0.446%
5/11/2022	GSA Capital Partners LLP	42,507	$0.23M	0.0%	+77.5%	0.108%
5/6/2022	Los Angeles Capital Management LLC	35,830	$0.19M	0.0%	+75.8%	0.091%
5/4/2022	Victory Capital Management Inc.	47,919	$0.16M	0.0%	-97.3%	0.121%
4/29/2022	Nisa Investment Advisors LLC	16,100	$86K	0.0%	N/A	0.041%
2/14/2022	PDT Partners LLC	33,057	$0.49M	0.0%	N/A	0.084%
2/14/2022	Virtus ETF Advisers LLC	13,677	$0.20M	0.1%	+26.9%	0.035%
2/14/2022	Corton Capital Inc.	16,912	$0.25M	0.1%	N/A	0.043%
2/14/2022	Suvretta Capital Management LLC	440,696	$6.48M	0.1%	+195.6%	1.119%
2/14/2022	GSA Capital Partners LLP	23,954	$0.35M	0.0%	N/A	0.061%
2/11/2022	Ensign Peak Advisors Inc	10,360	$0.15M	0.0%	N/A	0.026%
2/11/2022	Column Group LLC	3,568,181	$52.45M	7.1%	-25.2%	9.060%
2/10/2022	Rafferty Asset Management LLC	68,423	$1.01M	0.0%	+118.5%	0.174%
2/10/2022	Citigroup Inc.	61,233	$0.90M	0.0%	+130.6%	0.155%
2/8/2022	Jennison Associates LLC	985,072	$14.48M	0.0%	-1.5%	2.501%
2/8/2022	Swiss National Bank	56,300	$0.83M	0.0%	+7.0%	0.143%
2/8/2022	Northern Trust Corp	313,783	$4.61M	0.0%	-1.0%	0.797%
2/7/2022	Victory Capital Management Inc.	1,805,717	$26.54M	0.0%	+16.8%	4.585%
2/7/2022	SG Americas Securities LLC	13,650	$0.20M	0.0%	-45.9%	0.035%
2/7/2022	M&T Bank Corp	20,536	$0.30M	0.0%	+40.3%	0.052%
2/4/2022	Beacon Investment Advisory Services Inc.	15,000	$0.22M	0.0%	-14.6%	0.038%
2/2/2022	New York State Common Retirement Fund	19,557	$0.29M	0.0%	-17.5%	0.050%
1/28/2022	Allspring Global Investments Holdings LLC	1,000,199	$14.70M	0.0%	N/A	2.540%
1/24/2022	Regents of The University of California	148,322	$2.18M	0.3%	N/A	0.377%
11/22/2021	EcoR1 Capital LLC	3,468,944	$72.54M	2.5%	+12.2%	8.808%
11/17/2021	ArrowMark Colorado Holdings LLC	1,249,707	$26.13M	0.2%	+22.3%	3.173%
11/16/2021	Suvretta Capital Management LLC	149,100	$3.12M	0.1%	N/A	0.379%
11/16/2021	Laurion Capital Management LP	47,821	$1M	0.0%	-21.6%	0.121%
11/16/2021	Metropolitan Life Insurance Co NY	8,546	$0.18M	0.0%	+17.2%	0.022%
11/15/2021	Point72 Asset Management L.P.	333,782	$6.98M	0.0%	-64.6%	0.848%
11/15/2021	California State Teachers Retirement System	36,443	$0.76M	0.0%	-10.4%	0.093%
11/15/2021	Virtus ETF Advisers LLC	10,782	$0.23M	0.1%	-5.0%	0.027%
11/15/2021	Voya Investment Management LLC	183,512	$3.84M	0.0%	+19.9%	0.466%

Data available starting January 2016

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $8.07

$7.73

$8.13

50 Day Range

MA: $12.13

$7.67

$16.03

52 Week Range

Now: $8.07

$4.90

$16.65

Volume

401,560 shs

Average Volume

546,749 shs

Market Capitalization

$543.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top insider shareholders include:
Jacob Chacko (CEO)
Pratik S Multani (Insider)
Learn More about top insider investors at ORIC Pharmaceuticals.

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

4 simple steps to protect your privacy and money before it’s too late.

ORIC Insider Trading

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

ORIC Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?